Inhibition by retinoic acid of multiplication of virulent tubercle bacilli in cultured human macrophages.

Infection and Immunity
A J Crowle, E J Ross

Abstract

The immunologically active vitamin retinoic acid (RA) was tested for the ability to increase the resistance of cultured human macrophages (MP) to experimental infection with virulent Mycobacterium tuberculosis Erdman (tubercle bacilli [TB]). It was added to MP in various concentrations and addition regimens. Protection against TB was measured by counting live TB (CFU) in lysates of samples of MP taken at 0, 4, and 7 days after MP infection. RA was protective when added after infection at the pharmacologic concentration of 10(-5) M and when added before infection at the physiologic concentration of 10(-7) M. The protection lengthened intracellular generation times for TB, occasionally caused bacteriostasis, and regularly kept CFU counts at 7 days (end of the period of infection) 1 to 2 log10 CFU below control values. Significant protection was seen in a series of 16 experiments with MP from seven different donors, but the degree of protection varied considerably. The protection depended partly on and was inversely proportional to concentrations of a serum substitute or autologous serum used as a supplement in the RPMI 1640 MP culture medium. It was strongest at concentrations of serum below 1%. RA at concentrations used in the M...Continue Reading

References

Dec 17, 1987·Nature·V GiguereR M Evans
Apr 7, 1988·Biochimica Et Biophysica Acta·S R WassallW Stillwell
Apr 28, 1988·Nature·N BrandA Dejean
Dec 1, 1987·Proceedings of the Society for Experimental Biology and Medicine·J M GallupJ A Olson
Jan 1, 1987·Annual Review of Nutrition·F Chytil, D E Ong
Nov 1, 1986·The American Review of Respiratory Disease·A J CrowleM H May
Jul 1, 1987·The American Journal of Clinical Nutrition·F A CamposB A Underwood
Feb 10, 1968·Nature·D W Dresser
Feb 1, 1982·The Journal of Clinical Investigation·D Douer, H P Koeffler

❮ Previous
Next ❯

Citations

Jun 1, 1994·Alcoholism, Clinical and Experimental Research·G SzaboD Catalano
May 9, 2009·PloS One·Meetu SethSrinand Sreevatsan
Jun 11, 2014·Critical Reviews in Food Science and Nutrition·Surya KantSavita Ahluwalia
Sep 25, 2017·Nature Reviews. Drug Discovery·Stefan H E KaufmannRalf Bartenschlager
Mar 23, 2011·BMC Infectious Diseases·Takahiro TanakaNaoto Keicho
Dec 22, 1999·The Journal of Immunology : Official Journal of the American Association of Immunologists·D J Kusner, J Adams
Jan 1, 1990·Annals of the New York Academy of Sciences·D N McMurrayE Hernandez-Frontera
Feb 7, 2014·The Journal of Immunology : Official Journal of the American Association of Immunologists·Matthew WheelwrightPhilip T Liu
Feb 9, 2017·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Mark W TenfordeUNKNOWN NWCS319 and ACTG 5175 study team
May 23, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Omowunmi AibanaMegan B Murray
Dec 9, 2000·The Journal of Nutrition·E KaryadiC E West
Jun 1, 2018·American Journal of Respiratory Cell and Molecular Biology·Michelle M ColemanJoseph Keane
Oct 10, 2018·Frontiers in Cellular and Infection Microbiology·Nelita du PlessisGerhard Walzl
Feb 7, 2016·Biochimica Et Biophysica Acta·Thomas Gutsmann
Jul 3, 2021·Animals : an Open Access Journal From MDPI·Palazzo FiorentinaGiulietta Minozzi
Jun 11, 2021·The Journal of Veterinary Medical Science·Nuttapone SangkanjanavanichShinji Takai
Jun 16, 2009·Translational Research : the Journal of Laboratory and Clinical Medicine·Antje BlumenthalKyu Y Rhee

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.